|
|
|
|
| LEADER |
01874nam a2200217 a 4500 |
| 001 |
1873396 |
| 005 |
20171111234655.0 |
| 008 |
090811e200804uuxxka |s|||||||0|0 eng|d |
| 020 |
|
|
|a 9781847558275:
|c £102.35
|
| 020 |
|
|
|a 1847558275:
|c £102.35
|
| 040 |
|
|
|a UK-WkNB
|b eng
|
| 245 |
1 |
0 |
|a Therapeutic Oligonucleotides
|c Edited by Jens Kurreck; Series edited by David M J Lilley, Simon Campbell, Marius Clore; Contributions by Cy A Stein [et al.].
|
| 260 |
|
|
|a Cambridge,
|b Royal Society of Chemistry,
|c 2008.
|
| 300 |
|
|
|a 362 p. :
|b 113 b&w, ill.
|
| 500 |
|
|
|a Ebook.
|
| 505 |
0 |
|
|a Chapter 1: The Role of Backbone Modifications in Oligonucleotide-Based Strategies-- Chapter 2: Genasense (G3139): An Antisense Bcl-2 Oligodeoxyribonucleotide with Substantial Clinical Activity and a Complex Mechanism of Action-- Chapter 3: Antisense Morpholino Oligomers and Their Peptide Conjugates-- Chapter 4: Peptide-PNA Conjugates for Modulation of Gene Expression-- Chapter 5: Locked Nucleic Acid: Properties & Therapeutic Aspects-- Chapter 6: Immune Stimulatory Oligonucleotides-- Chapter 7: Decoy Oligonucleotides to Treat Inflammatory Diseases-- Chapter 8: AS1411: Development of an Anticancer Aptamer-- Chapter 9: Spielgelmer NOX-E36 for Renal Diseases-- Chapter 10: Strategies for the Delivery of Oligonucleotides In Vivo-- Chapter 11: Lipid-Mediated in vivo Delivery of Small Interfering RNAs-- Chapter 12: Vector-Mediated and Viral Delivery of Short Hairpin RNAs-- Chapter 13: Development of an RNAi Based Gene Therapy against HIV-1-- Chapter 14: RNA Based Therapies for Treatment of HIV Infection.
|
| 650 |
|
7 |
|a Proteins.
|
| 650 |
|
7 |
|a Medicine: general issues.
|
| 700 |
1 |
|
|a Maclachlan, Ian,
|c Dr.
|c Dr.
|c Dr.
|c Dr.
|c Professor.
|c Dr.
|c Dr.
|c Dr.
|c Dr.
|c Professor.
|c Dr.
|
| 856 |
4 |
|
|c Dr.
|u http://dx.doi.org/10.1039/9781847558275
|
| 952 |
|
|
|a CY-NiOUC
|b 5a0461cb6c5ad14ac1ee5e9b
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|
